Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   Sensitivity of mesothelioma cells to PARP inhibitors is not dependent on BAP1 but is enhanced by temozolomide in cells with high-Schlafen 11and low-MGMT expression
  2. Rathkey, Daniel; Khanal, Manakamana; Murai, Junko; Zhang, Jingli; Sengupta, Manjistha; Jiang, Qun; Morrow, Betsy; Evans,Christine; Chari,Raj; Fetsch, Patricia; Chung, Hye-Jung; Xi, Liqiang; Roth, Mark; Filie, Armando; Raffeld, Mark; Thomas, Anish; Pommier, Yves; Hassan, Raffit
  3. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020, Jan 28; pii: S1556-0864(20)30035-6.
  1. 2.   Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity
  2. Ruff, William E; Dehner, Carina; Kim, Woo J; Pagovich, Odelya; Aguiar, Cassyanne L; Yu, Andrew T; Roth, Alexander S; Vieira, Silvio Manfredo; Kriegel, Christina; Adeniyi, Olamide; Mulla, Melissa J; Abrahams, Vikki M; Kwok, William W; Nussinov,Ruth; Erkan, Doruk; Goodman, Andrew L; Kriegel, Martin A
  3. Cell host & microbe. 2019, Jul 10; 26(1): 100-113.e8.
  1. 3.   In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines
  2. Behrsing, H. P.; Furniss, M. J.; Robillard, K. A.; Tomaszewski, J. E.; Parchment, R. E.
  3. Cancer Chemotherapy and Pharmacology. 2010, May; 65(6): 1083-1091.
  1. 4.   Synthesis and Hybridization Properties of Modified Oligodeoxynucleotides Carrying Non-Natural Bases
  2. Avino, A.; Perez-Rentero, S.; Garibotti, A. V.; Siddiqui, M. A.; Marquez, V. E.; Eritja, R.
  3. Chemistry & Biodiversity. 2009 6(2): 117-126.
  1. 5.   Structural Basis for Binding of RNA and Cofactor by a KsgA Methyltransferase
  2. Tu, C.; Tropea, J. E.; Austin, B. P.; Court, D. L.; Waugh, D. S.; Ji, X. H.
  3. Structure. 2009 17(3): 374-385.
  1. 6.   2 '-deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: A novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase
  2. Byun, H. M.; Choi, S. H.; Laird, P. W.; Trinh, B.; Siddiqui, M. A.; Marquez, V. E.; Yang, A. S.
  3. Cancer Letters. 2008 266(2): 238-248.
  1. 7.   Degradation of BRCA2 in Alkyltransferase-Mediated DNA Repair and Its Clinical Implications
  2. Philip, S.; Swaminathan, S.; Kuznetsov, S. G.; Kanugula, S.; Biswas, K.; Chang, S.; Loktionova, N. A.; Haines, D. C.; Kaldis, P.; Pegg, A. E.; Sharant, S. K.
  3. Cancer Research. 2008 68(23): 9973-9981.
  1. 8.   Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice
  2. Yoo, C. B.; Chuang, J. C.; Byun, H. M.; Egger, G.; Yang, A. S.; Dubeau, L.; Long, T.; Laird, P. W.; Marquez, V. E.; Jones, P. A.
  3. Cancer Prevention Research. 2008 1(4): 233-240.
  1. 9.   Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia
  2. Shen, M.; Purdue, M. R.; Kricker, A.; Lan, Q.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Chanock, S.; Rothman, N.; Armstrong, B. K.
  3. Haematologica-the Hematology Journal. 2007, Sep; 92(9): 1180-1185.
  1. 10.   The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma
  2. Herranz, M.; Martin-Caballero, J.; Fraga, M. F.; Ruiz-Cabello, J.; Flores, J. M.; Desco, M.; Marquez, V.; Esteller, M.
  3. Blood. 2006, FEB 1; 107(3): 1174-1177.
  1. 11.   High-content fluorescence-based screening for epigenetic-modulators
  2. Martinez, E. D.; Dull, A. B.; Beutler, J. A.; Hager, G. L.
  3. Measuring Biological Responses with Automated Microscopy. 2006; 414 : 21-36.
  1. 12.   Phase I trial of temozolomide plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma
  2. Quinn, J. A.; Desjardins, A.; Weingart, J.; Brem, H.; Dolan, M. E.; Delaney, S. M.; Vredenburgh, J.; Rich, J.; Friedman, A. H.; Reardon, D. A.; Sampson, J. H.; Pegg, A. E.; Moschel, R. C.; Birch, R.; McLendon, R. E.; Provenzale, J. M.; Gururangan, S.; Dancey, J. E.; Maxwell, J.; Tourt-Uhlig, S.; Herndon, J. E.; Bigner, D. D.; Friedman, H. S.
  3. Journal of Clinical Oncology. 2005, OCT 1; 23(28): 7178-7187.
  1. 13.   Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
  2. Ben-Kasus, T.; Ben-Zvi, Z.; Marquez, V. E.; Kelley, J. A.; Agbaria, R.
  3. Biochemical Pharmacology. 2005, JUL 1; 70(1): 121-133.
  1. 14.   Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation
  2. Hodge, D. R.; Peng, B.; Cherry, J. C.; Hurt, E. M.; Fox, S. D.; Kelley, J. A.; Munroe, D. J.; Farrar, W. L.
  3. Cancer Research. 2005, JUN 1; 65(11): 4673-4682.
  1. 15.   A bifunctional DNA repair protein from Ferroplasma acidarmanus exhibits O-6-alkylguanine-DNA alkyltransferase and endonuclease V activities
  2. Kanugula, S.; Pauly, G. T.; Moschel, R. C.; Pegg, A. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, MAR 8; 102(10): 3617-3622.
  1. 16.   Preferential response of cancer cells to zebularine
  2. Cheng, J. C.; Yoo, C. B.; Weisenberger, D. J.; Chuang, J.; Wozniak, C.; Liang, G. N.; Marquez, V. E.; Greer, S.; Orntoft, T. F.; Thykjaer, T.; Jones, P. A.
  3. Cancer Cell. 2004, AUG; 6(2): 151-158.
  1. 17.   Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells
  2. Cheng, J. C.; Weisenberger, D. J.; Gonzales, F. A.; Liang, G. N.; Xu, G. L.; Hu, Y. G.; Marquez, V. E.; Jones, P. A.
  3. Molecular and Cellular Biology. 2004 24(3): 1270-1278.
  1. 18.   Glycine N-methyltransferase tumor susceptibility gene in the benzo(a)pyrene-detoxification pathway
  2. Chen, S. Y.; Lin, J. R. V.; Darbha, R.; Lin, P. P.; Liu, T. Y.; Chen, Y. M. A.
  3. Cancer Research. 2004 64(10): 3617-3623.
  1. 19.   The repair of the tobacco specific nitrosamine derived adduct O-6-[4-oxo-4-(3-pyridyl)butyl]guanine by O-6-alkylguanine-DNA alkyltransferase variants
  2. Mijal, R. S.; Thomson, N. M.; Fleischer, N. L.; Pauly, G. T.; Moschel, R. C.; Kanugula, S.; Fang, Q. M.; Pegg, A. E.; Peterson, L. A.
  3. Chemical Research in Toxicology. 2004 17(3): 424-434.
  1. 20.   Epigenetic control during lymphoid development and immune responses - Aberrant regulation, viruses, and cancer
  2. Muegge, K.; Young, H.; Ruscetti, F.; Mikovits, J.
  3. Epigenetics in Cancer Prevention: Early Detection and Risk Assessment. 2003; 983 : 55-70.
  1. 21.   Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (Zebularine) at the G(C)under-barGC recognition domain
  2. Marquez, V. E.; Eritja, R.; Kelley, J. A.; Vanbemmel, D.; Christman, J.
  3. THERAPEUTIC OLIGONUCLEOTIDES. 2003; 1002 : 154-164.
  1. 22.   Inhibition of HhaI DNA (cytosine-C5) methyltransferase by oligodeoxyribonucleotides containing 5-aza-2 '-deoxycytidine: Examination of the intertwined roles of co-factor, target, transition state structure and enzyme conformation
  2. Brank, A. S.; Eritja, R.; Garcia, R. G.; Marquez, V. E.; Christman, J. K.
  3. Journal of Molecular Biology. 2002 323(1): 53-67.
  1. 23.   Phase II trial of carmustine plus O-6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma
  2. Quinn, J. A.; Pluda, J.; Dolan, M. E.; Delaney, S.; Kaplan, R.; Rich, J. N.; Friedman, A. H.; Reardon, D. A.; Sampson, J. H.; Colvin, O. M.; Haglund, M. M.; Pegg, A. E.; Moschel, R. C.; McLendon, R. E.; Provenzale, J. M.; Gururangan, S.; Tourt-Uhlig, S.; Herndon, J. E.; Bigner, D. D.; Friedman, H. S.
  3. Journal of Clinical Oncology. 2002 20(9): 2277-2283.
  1. 24.   DNA adducts and liver DNA replication in rats during chronic exposure to N-nitrosodimethylamine (NDMA) and their relationships to the dose-dependence of NDMA hepatocarcinogenesis
  2. Souliotis, V. L.; Henneman, J. R.; Reed, C. D.; Chhabra, S. K.; Diwan, B. A.; Anderson, L. M.; Kyrtopoulos, S. A.
  3. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2002 500(1-2): 75-87.
  1. 25.   Lsh, a member of the SNF2 family, is required for genome-wide methylation
  2. Dennis, K.; Fan, T.; Geiman, T.; Yan, Q. S.; Muegge, K.
  3. Genes & Development. 2001 15(22): 2940-2944.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel